Financing

Share Buybacks

Eli Lilly Share Buybacks increased by 56.3% to $2.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 96.3%, from $1.20B to $2.36B. Over 2 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 81.3% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026

How to read this metric

High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.

Detailed definition

The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...

Peer comparison

Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.

Metric ID: share_repurchases

Historical Data

14 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q1 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$500.00M$0.00$750.00M$1.50B$750.00M$0.00$0.00$446.10M$2.05B$1.20B$692.20M$708.10M$1.51B$2.36B
QoQ Change-100.0%+100.0%-50.0%-100.0%+360.4%-41.6%-42.3%+2.3%+112.9%+56.3%
YoY Change-50.0%-100.0%+58.7%-26.6%+96.3%
Range$0.00$2.36B
CAGR+61.1%
Avg YoY Growth-4.3%
Median YoY Growth-26.6%
Current Streak3 quarters growth

Frequently Asked Questions

What is Eli Lilly's share buybacks?
Eli Lilly (LLY) reported share buybacks of $2.36B in Q1 2026.
How has Eli Lilly's share buybacks changed year-over-year?
Eli Lilly's share buybacks increased by 96.3% year-over-year, from $1.20B to $2.36B.
What is the long-term trend for Eli Lilly's share buybacks?
Over 2 years (2021 to 2025), Eli Lilly's share buybacks has grown at a 81.3% compound annual growth rate (CAGR), from $1.25B to $4.11B.
What does share buybacks mean?
Cash spent by the company to buy back its own stock.